Clinical Trial Update: Bevacizumab in Treating Patients With Myelodysplastic Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Bevacizumab was studied in patients with myelodysplastic syndrome in Phase 1 and Phase 2 trials. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Stanford University | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: COMPLETED